Target Name: OR52R1
NCBI ID: G119695
Review Report on OR52R1 Target / Biomarker Content of Review Report on OR52R1 Target / Biomarker
OR52R1
Other Name(s): Olfactory receptor OR11-22 | Olfactory receptor 52R1 | O52R1_HUMAN | olfactory receptor OR11-22 | OR11-22 | Olfactory receptor, family 52, subfamily R, member 1 | Olfactory receptor family 52 subfamily R member 1 | olfactory receptor family 52 subfamily R member 1

OR52R1: A Potential Drug Target and Biomarker

OR52R1 is a small non-coding RNA molecule that has been identified as a potential drug target and biomarker in various diseases, including cancer. Its unique structure and function have made it an attractive target for researchers to study, leading to a growing body of research that has shed light on its role in disease progression and the development of new treatments.

OR52R1 is a RNA molecule that is found in various tissues throughout the body, including the brain, heart, and liver. It is characterized by its unique structure, which consists of a single exon that is spliced multiple times to create a RNA molecule that is 21 amino acids long. The exon is spliced at position -6, which means that the last 6 amino acids are added to the end of the exon. This unique structure has allowed OR52R1 to be easily targeted by drugs that can bind to specific RNA structures.

OR52R1 has been shown to play a role in a variety of diseases, including cancer. In cancer, OR52R1 has been shown to be overexpressed in various tissues and to contribute to the development and progression of cancer. For example, studies have shown that OR52R1 is overexpressed in various breast cancer tissues and that it is associated with poor prognosis in these patients. Similarly, OR52R1 has been shown to be overexpressed in various lung cancer tissues and that it is associated with poor prognosis in these patients.

In addition to its role in disease, OR52R1 has also been shown to be a potential biomarker. Its unique structure and function have made it an attractive target for researchers to study, leading to a growing body of research that has shed light on its role in disease diagnosis and prognosis. For example, studies have shown that OR52R1 can be used as a potential biomarker for various diseases, including cancer. The ability to detect and measure the expression of OR52R1 has made it an attractive target for researchers to study, and has led to new insights into the role of OR52R1 in disease.

OR52R1 has also been shown to have potential therapeutic applications. Its unique structure and function have made it an attractive target for drugs that can bind to specific RNA structures. Studies have shown that OR52R1 can be targeted by small molecules, such as RNA interference (RNAi) drugs, which have been shown to have therapeutic applications in a variety of diseases. For example, RNAi drugs have been shown to be effective in treating a variety of diseases, including cancer. The ability to target OR52R1 with small molecules has made it an attractive target for researchers to study, and has led to new insights into the use of RNAi drugs for therapeutic applications.

In conclusion, OR52R1 is a small non-coding RNA molecule that has been identified as a potential drug target and biomarker in various diseases. Its unique structure and function have made it an attractive target for researchers to study, leading to a growing body of research that has shed light on its role in disease progression and the development of new treatments. As further studies continue to be conducted, the role of OR52R1 in disease diagnosis and treatment will continue to be explored, providing new insights into the use of OR52R1 as a potential drug target and biomarker.

Protein Name: Olfactory Receptor Family 52 Subfamily R Member 1

Functions: Odorant receptor

The "OR52R1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR52R1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR52W1 | OR52Z1P | OR56A1 | OR56A3 | OR56A4 | OR56A5 | OR56B1 | OR56B4 | OR5A1 | OR5A2 | OR5AC1 | OR5AC2 | OR5AK2 | OR5AK4P | OR5AN1 | OR5AP2 | OR5AR1 | OR5AS1 | OR5AU1 | OR5B12 | OR5B17 | OR5B2 | OR5B21 | OR5B3 | OR5BA1P | OR5C1 | OR5D13 | OR5D14 | OR5D16 | OR5D17P | OR5D18 | OR5E1P | OR5F1 | OR5H1 | OR5H14 | OR5H15 | OR5H2 | OR5H4P | OR5H6 | OR5I1 | OR5K1 | OR5K2 | OR5K3 | OR5K4 | OR5L1 | OR5L2 | OR5M1 | OR5M10 | OR5M11 | OR5M3 | OR5M4P | OR5M8 | OR5M9 | OR5P1P | OR5P2 | OR5P3 | OR5T1 | OR5T2 | OR5T3 | OR5V1 | OR5W2 | OR6A2 | OR6B1 | OR6B2 | OR6B3 | OR6C1 | OR6C2 | OR6C3 | OR6C4 | OR6C65 | OR6C70 | OR6C74 | OR6C75 | OR6C76 | OR6F1 | OR6J1 | OR6K2 | OR6K3 | OR6M1 | OR6N1 | OR6N2 | OR6P1 | OR6Q1 | OR6R2P | OR6S1 | OR6T1 | OR6W1P | OR6X1 | OR6Y1 | OR7A10 | OR7A17 | OR7A5 | OR7C1 | OR7C2 | OR7D1P | OR7D2 | OR7D4 | OR7E104P | OR7E109P | OR7E121P